We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-2 of 2

Federal Court sets aside decision of the PMPRB that lacks “transparency, intelligibility and justification” QUADRACEL and PENTACEL
  • Norton Rose Fulbright Canada LLP
  • Canada
  • July 14 2011

On July 12, 2011 Gauthier J. of the Federal Court (the “Court”) allowed the judicial review application of Sanofi Pasteur Limited (“Sanofi”) and quashed the March 16, 2010 Order of the Patented Medicine Prices Review Board (the “Board”